Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
2-year Outcome
100%
Accelerated Treatment
14%
Acute Toxicity
14%
Beam Intensity
14%
Cancer 2
100%
Cisplatin-based Chemotherapy
14%
Clinical Application
14%
Clinical Outcomes
14%
Common Terminology Criteria for Adverse Events (CTCAE)
14%
Concurrent Cisplatin
14%
Descriptive Statistics
14%
Distant Metastasis
42%
Dosimetric
14%
Dosimetry
14%
Early Outcome
14%
Epstein-Barr Virus
14%
Hyperfractionated
14%
Induction Chemotherapy
14%
Intensity-modulated Proton Therapy
100%
Kaplan-Meier
14%
Kaplan-Meier Method
14%
Late Toxicity
14%
Local Failure
14%
Local-regional Control
42%
Nasopharyngeal Carcinoma
71%
Nasopharynx Cancer
100%
Node-positive
14%
Once-daily
14%
Overall Survival
28%
Pencil Beam
14%
Primary Tumor
14%
Proton Therapy
14%
Radiotherapy
42%
Recurrent Nasopharyngeal Carcinoma
14%
Reduced Toxicity
14%
Regional Failure
14%
Single Institution
100%
Stage III-IV
14%
T3, T4
14%
T4 Disease
14%
Technological Progress
14%
Therapeutic Ratio
14%
Toxicity Outcomes
14%
Toxicity Profile
14%
Treatment Record
14%
Treatment Volume
14%
Tumor
14%
Tumor Control
14%
Tumor Response
14%
Twice Daily
14%
Medicine and Dentistry
Adverse Event
12%
Cisplatin
12%
Critical Structure
12%
Diseases
25%
Distant Metastasis
37%
Dosimetry
12%
Epstein Barr Virus
12%
Induction Chemotherapy
12%
Kaplan Meier Method
12%
Nasopharynx Cancer
100%
Nasopharynx Carcinoma
75%
Neoplasm
37%
Overall Survival
25%
Primary Tumor
12%
Proton Therapy
100%
Radiation Therapy
37%
Relative Biologic Effectiveness
12%
Therapeutic Window
12%